Regeneron Pharmaceuticals has agreed to acquire the assets of bankrupt genetic testing company 23andMe for $256 million. Regeneron pledged to 'ensure compliance with 23andMe's consumer privacy policies and applicable laws with respect to the treatment of customer data.' This is a big loss for 23andMe co-founder and former CEO Anne Wojcicki, who'd been trying to buy the company since last summer.
Innovative Health has been awarded $147 million in damages from a lawsuit against Biosense Webster relating to the J&J business's policy to withhold cardiac mapping support services from hospitals that chose to purchase reprocessed catheters from Innovative instead of Biosense's new devices.
Gartner describes a cloud ecosystem that's smarter, greener, and more integral to business success than ever before - despite widespread dissatisfaction.
HHS Secretary Robert F. Kennedy Jr. is promising to 'do more with less' — with the help of AL. 'The AI revolution has arrived, and we are already using these new technologies to manage health care data more efficiently and securely,' he told the House Appropriations Committee at this week's hearing on HHS’ budget.
In the brief, YC charged that Google is a “monopolist” that has “stunted” the U.S. startup ecosystem by making VC firms like itself hesitate to fund web search and AI startups in what it calls a “kill zone” around Google.
Epic Systems is perhaps the most successful health technology company in the world. Its electronic health record (EHR) platform is now used by the majority of large health systems in the U.S. Its customers are vocal in their support and are often passionate defenders of the platform’s reliability, configurability, and comprehensiveness. And its commercial success continues: according to newly released KLAS Research data, Epic gained even more market share in 2024, widening the gap between itself and competitors.